Atopic Dermatitis Market Treatment, Symptoms, Causes and Pipeline Review, H2 2016 by Radiant Insights

“Radiant Insights” has include “Atopic Dermatitis Market Report H2 2016” Size, Share, Growth Prospects to their Database.

Radiant Insights’s, ‘Atopic Dermatitis – Pipeline Review, H2 2016’, provides an overview of the Atopic Dermatitis pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Atopic Dermatitis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Atopic Dermatitis and features dormant and discontinued projects.

Read Complete Report with TOC @

Radiant Insights’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Radiant Insights’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.


– The report provides a snapshot of the global therapeutic landscape of Atopic Dermatitis
– The report reviews pipeline therapeutics for Atopic Dermatitis by companies and universities/research institutes based on information derived from company and industry-specific sources
– The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
– The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
– The report reviews key players involved Atopic Dermatitis therapeutics and enlists all their major and minor projects
– The report assesses Atopic Dermatitis therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
– The report summarizes all the dormant and discontinued pipeline projects
– The report reviews latest news related to pipeline therapeutics for Atopic Dermatitis

Related Reports by Radiant Insights:
Duchenne Muscular Dystrophy – Pipeline Review, H2 2016 –

Candidiasis – Pipeline Review, H2 2016 –

Reasons to buy
– Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
– Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
– Identify and understand important and diverse types of therapeutics under development for Atopic Dermatitis
– Identify potential new clients or partners in the target demographic
– Develop strategic initiatives by understanding the focus areas of leading companies
– Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics
– Devise corrective measures for pipeline projects by understanding Atopic Dermatitis pipeline depth and focus of Indication therapeutics
– Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
– Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline

Browse More Categories @

Table of Contents
Table of Contents 2
List of Tables 8
List of Figures 11
Introduction 12
Radiant Insights Report Coverage 12
Atopic Dermatitis Overview 13
Therapeutics Development 14
Pipeline Products for Atopic Dermatitis – Overview 14
Pipeline Products for Atopic Dermatitis – Comparative Analysis 15
Atopic Dermatitis – Therapeutics under Development by Companies 16
Atopic Dermatitis – Therapeutics under Investigation by Universities/Institutes 22
Atopic Dermatitis – Pipeline Products Glance 23
Late Stage Products 23
Clinical Stage Products 24
Early Stage Products 25
Unknown Stage Products 26
Atopic Dermatitis – Products under Development by Companies 27
Atopic Dermatitis – Products under Investigation by Universities/Institutes 35
Atopic Dermatitis – Companies Involved in Therapeutics Development 36
AbbVie Inc 36
Accolade Pharmaceuticals, LLC 37
AlbireoPharma 38
Almirall, S.A. 39
Amgen Inc. 40

Buy a Sample copy of This Report @

About Us:
Radiant Insights Inc. is a platform for companies looking to meet their market research and business intelligence requirements. We assist and facilitate organizations and individuals procure market research reports, helping them in the decision making process. We have a comprehensive collection of reports, covering over 40 key industries and a host of micro markets. In addition to over extensive database of reports, our experienced research coordinators also offer a host of ancillary services such as, research partnerships/ tie-ups and customized research solutions.

Media Contact
Company Name: Radiant Insights, Inc.
Contact Person: Michelle Thoras, Corporate Sales Specialist – USA
Phone: (415) 349-0054, Toll Free: 1-888-202-9519
Address:28 2nd Street, Suite 3036
City: San Francisco
State: California
Country: United States